• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders

PRAH

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

49.1%

Avg Negative

2.3%

Avg Neutral

48.6%

News Feed

Veranex Announces Investment From Summit Partners to Form Comprehensive Concept-to-Commercialization Medtech Services Company

Business Wire·6/16/2021·↑ positive

Here's Why You Should Retain PRA Health (PRAH) Stock for Now

Zacks Investment Research·6/1/2021·↑ positive

PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with Synoma

GlobeNewsWire
·5/13/2021
·↑ positive

PRA Health (PRAH) Stock Down 0.3% Despite Q1 Earnings Beat

Zacks Investment Research·5/4/2021·↑ positive

PRA HEALTH SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PRA Health Sciences, Inc. - PRAH

Business Wire·4/29/2021·↓ negative

PRA Health Sciences (PRAH) Q1 Earnings and Revenues Beat Estimates

Zacks Investment Research·4/28/2021·↑ positive

PRA Health Sciences, Inc. Reports First Quarter 2021 Results

GlobeNewsWire·4/28/2021·↓ negative

PRA Health Sciences expands its response to COVID-19 with pharmacovigilance solutions for authorized vaccines and therapeutics

GlobeNewsWire·4/21/2021·↑ positive

PRA Health Sciences (PRAH) Surges 3.8%: Is This an Indication of Further Gains?

Zacks Investment Research·4/16/2021·↑ positive

PRA Health (PRAH) Chosen by MedChi to Offer Telehealth Services

Zacks Investment Research·4/14/2021·↑ positive